The International Trachoma Initiative (ITI) is a nonprofit organization based in New York, NY, dedicated to eliminating blinding trachoma worldwide. ITI works in partnership with various stakeholders, including WHO Member States, research institutions, philanthropic foundations, and industry, to provide stewardship for the Pfizer donation of Zithromax, an effective antibiotic for trachoma treatment. Through their efforts, ITI has shipped over one billion doses of Zithromax to countries in need, contributing to the global goal of trachoma elimination by 2030.
Founded in 1998, ITI was established as a result of a collaboration between Pfizer and The Edna McConnell Clark Foundation. The organization plays a crucial role in generating and providing access to data and knowledge about trachoma, strengthening partnerships for disease elimination, and supporting the global trachoma program. With a focus on the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, and Environmental improvement), ITI has made significant milestones in combating trachoma, working towards a world free from this preventable and treatable disease.
Generated from the website